Showing results (11-20 of 135) with videos related to
Sort By:
Pageof 14
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1987
[Absence of transplacental passage of Fraxiparin (low molecular weight heparin) during the 3d trimester of pregnancy]F Forestier, F Daffos, M Rainaut, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1996
[Biological monitoring and prevention of complications from antithrombotic agents]M M Samama, A KherClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 8, 2001
Low-molecular-weight heparins: weeks or months instead of days of treatmentA Kher, M M SamamaJournal of Thrombosis and Haemostasis : JTH|March 8, 2005
Primary and secondary prophylaxis of venous thromboembolism with low-molecular-weight heparins: prolonged thromboprophylaxis, an alternative to vitamin K antagonistsA Kher, M M SamamaInternational Journal of Clinical Practice|April 29, 2005
Venous thromboembolism in the medically ill patient: a call to actionJ-F Bergmann, A KherArchives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1996
[Low molecular weight heparin in unstable angina]A Kher, M M SamamaThrombosis Research|October 15, 1992
Effects of aprotinin on heparin activities and heparin neutralization with protamineF Azougagh Oualane, F Toulemonde, F Doutremepuich, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1983
[Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia]J Roussi, L Houbouyan, D Rosenthal, et al.Indian Journal of Pathology & Microbiology|July 1, 1997
Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breastA Kher, G Moghe, A DeshpandeClinical Cardiology|July 11, 2001
A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery diseaseS Husted, R Becker, A KherPageof 14